美国 Medicare 患者输尿管镜碎石术后不良结局的危险因素
分析 2019 至 2023 年间 290,610 例≥65 岁接受输尿管镜(URS)的 Medicare 患者,评估九项危险因素的患病率及其与 30 天内脓毒症、ICU 入住、延长住院时间和 90 天内死亡的关系。94.4% 患者有至少 1 项危险因素,有危险因素者不良结局发生率更高;有脓毒症史者脓毒症、30 天内 ICU 入住和 90 天内死亡发生率分别为 30.3%、2.5% 和 0.86%,而无脓毒症史者分别为 2.2%、0.80% 和 0.18%(均 P<.001)。
要点
- 290,610 例 Medicare URS 患者中 94.4% 有至少 1 项、76.3% 有至少 2 项危险因素。
- 有脓毒症史者脓毒症发生率 30.3%,无脓毒症史者 2.2%(P<.001)。
- 有脓毒症史者中位住院时间 5 天,无脓毒症史者 3 天(P<.001)。
核心结论
- 多数接受 URS 的 Medicare 患者存在危险因素,有危险因素者更易发生脓毒症、ICU 入住、住院时间延长和死亡。
- 作者认为这些发现强调需要对高危 URS 患者进行针对性预防和谨慎管理。
研究设计与样本
- 分析 2019 至 2023 年间接受 URS 的≥65 岁 Medicare 患者数据。
- 共纳入 290,610 例患者,评估九项危险因素的患病率及其与不良结局的关联。
主要发现
- 94.4%(n=274,396)患者有至少 1 项危险因素,76.3% 有至少 2 项危险因素。
- 各危险因素占比:年龄>70 岁 64.6%、术前支架 59.4%、女性 46.4%、3 个月内尿路感染 39.1%、糖尿病 33.0%、脓毒症史 17.3%、6 个月内多次尿路感染 13.1%、Charlson 合并症指数≥7 分 10.2%、缺血性心脏病 2.9%。
- 有脓毒症史者脓毒症发生率 30.3% vs 无脓毒症史者 2.2%(P<.001)。
- 有脓毒症史者 30 天内 ICU 入住率 2.5% vs 无脓毒症史者 0.80%(P<.001)。
- 有脓毒症史者 90 天内死亡率 0.86% vs 无脓毒症史者 0.18%(P<.001);有脓毒症史者中位住院时间 5 天 vs 无脓毒症史者 3 天(P<.001)。
临床怎么用
- 作者认为这些发现强调需要对高危 URS 患者进行针对性预防和谨慎管理。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the proportion of US Medicare patients undergoing ureteroscopy (URS) for kidney stone management at risk for adverse outcomes and analyze the association between risk factors and adverse events. METHODS: Data from Medicare patients aged ≥65 who underwent URS between 2019 and 2023 were analyzed. Nine risk factors were examined for their prevalence and association with sepsis and intensive care unit (ICU) admission within 30 days, extended length of stay (LOS) during the index procedure, and death within 90 days. RESULTS: Among 290,610 Medicare patients who underwent URS, 94.4% had ≥1 (n = 274,396) and 76.3% had ≥2 risk factors. The proportion of patients with each risk factor was: age over 70 (64.6%), preoperative stent (59.4%), female (46.4%), urinary tract infection within 3 months (39.1%), diabetes (33.0%), history of sepsis (17.3%), multiple urinary tract infections within 6 months (13.1%), Charlson Comorbidity Index score of ≥7 (10.2%), and ischemic heart disease (2.9%). Patients with risk factors experienced a higher incidence of adverse outcomes. Notably, among patients with sepsis history, the incidence of sepsis, ICU admission within 30 days, and death within 90 days were 30.3%, 2.5%, and 0.86%, respectively, versus, 2.2%, 0.80%, and 0.18% without sepsis history (all P <.001). Median LOS was 5 days among patients with sepsis history versus 3 days without (P <.001). CONCLUSION: Most URS Medicare patients had risk factors. Those with risk factors were more likely to experience sepsis, ICU admission, prolonged hospital LOS, and death. These findings underscore the need for targeted prevention and careful management for high-risk URS patients.
引用
- Monga M, Sato R, White J, et al. Risk Factors for Adverse Outcomes Following Ureteroscopy for Stone Management in US Medicare Patients. Urology. 2025. PMID: 39978600. doi:10.1016/j.urology.2025.02.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。